About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
IVA
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Inventiva GAAP EPS of -€1.31 misses by €0.02, revenue of €12.18M misses by €0.44M
- Inventiva draws down €25M tranche under contract with the EIB
- Inventiva stock dips as AbbVie abandons cedirogant program for autoimmune disease
- Inventiva GAAP EPS of -$0.72, revenue of $67M
- Inventiva, Sino Biopharm sign licensing pact to develop, commercialize NASH treatment
- Inventiva reports Q1 results
- Inventiva gets FDA nod to begin phase 2 trial to treat diabetes/liver disease
- Inventiva GAAP EPS of -€1.27, revenue of €4.2M
- Inventiva gets €4M milestone payment from AbbVie in cedirogant trial to treat psoriasis
- Inventiva reports Q3 results
- FDA grants Fast Track status to Inventiva's lanifibranor in NASH with compensated cirrhosis
- Inventiva reports 1H results
- Inventiva lays out trial design for late-stage lanifibranor study in NASH
- Seeking Alpha Catalyst Watch
- Inventiva's odiparcil nabs accelerated review in U.S. for a rare genetic disorder
- Inventiva nabs Breakthrough Device tag for its lead candidate for NASH
- Inventiva reports 1H results
- Inventiva files for IPO
Earnings History
Date | EPS / Forecast | Revenue / Forecast | |
---|---|---|---|
November 10, 2021 | - / -0.29 | 200K / 4.2M |
Beat! |
September 20, 2021 | -0.6 / -0.68 | 139.0K / 2M |
Beat! |
May 12, 2021 | - / -0.27 | - / 2M | |
March 4, 2021 | -0.39 / -0.39 | 3M / 3M | |
November 12, 2020 | -0.32 / -0.32 | 2M / 2M | |
September 16, 2020 | -0.3 / -0.54 | 1M / 2M | |
May 14, 2020 | -0.23 / - | 1M / - |
Beat! |
March 10, 2020 | -0.39 / - | 5.67M / 1.40M |
Beat! |
November 13, 2019 | - / - | - / - | |
September 25, 2019 | -0.93 / - | 1.33M / 1.99M |
Date | Price | Open | High | Low | Vol | Change | ER | |||
---|---|---|---|---|---|---|---|---|---|---|
Mar 9 | 9.95 | 10.00 |
10.20
|
9.82
|
24.07K | -0.5% | ||||
Mar 8 | 10.00 | 10.10 |
10.60
|
9.90
|
16.35K | -1.19% | ||||
Mar 7 | 10.12 | 10.14 |
10.14
|
9.20
|
51.31K | -0.78% | ||||
Mar 4 | 10.20 | 10.60 |
10.74
|
10.20
|
30.46K | -4.67% | ||||
Mar 3 | 10.70 | 10.92 |
10.92
|
10.40
|
13.63K | -1.83% | ||||
Mar 2 | 10.90 | 11.10 |
11.10
|
10.60
|
13.39K | -1.8% | ||||
Mar 1 | 11.10 | 11.14 |
11.50
|
10.90
|
43.82K | 0.54% | ||||
Feb 28 | 11.04 | 10.50 |
11.14
|
10.50
|
41.36K | 2.60% | ||||
Feb 25 | 10.76 | 10.30 |
10.82
|
10.00
|
22.51K | 9.02% | ||||
Feb 24 | 9.87 | 10.20 |
10.48
|
9.61
|
55.12K | -8.61% | ||||
Feb 23 | 10.80 | 10.40 |
10.80
|
10.28
|
26.12K | 5.47% | ||||
Feb 22 | 10.24 | 10.40 |
10.40
|
10.00
|
29.86K | -3.4% | ||||
Feb 21 | 10.60 | 10.84 |
10.98
|
10.60
|
14.39K | -3.64% | ||||
Feb 18 | 11.00 | 10.88 |
11.04
|
10.80
|
11.55K | 1.29% | ||||
Feb 17 | 10.86 | 11.14 |
11.16
|
10.86
|
10.34K | -2.16% | ||||
Feb 16 | 11.10 | 11.26 |
11.26
|
11.08
|
6.60K | -0.36% | ||||
Feb 15 | 11.14 | 11.06 |
11.32
|
11.06
|
6.07K | 0.36% | ||||
Feb 14 | 11.10 | 11.76 |
11.76
|
11.00
|
32.84K | -7.19% | ||||
Feb 11 | 11.96 | 11.96 |
12.00
|
11.86
|
33.38K | 0.50% | ||||
Feb 10 | 11.90 | 11.90 |
11.96
|
11.88
|
6.94K | 0% |